用户28964502982022-07-08 16:40
$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文
牛唐2022-07-08 15:08
韩国SD Biosensor和SJL Partners (Consortium)以15.3亿美元全现金收购$美鼎生物(VIVO)$ 。
$东方生物(SH688298)$ $金域医学(SH603882)$查看全文
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-21-029298 Size: 6 KB 网页链接
$美鼎生物(VIVO)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001193125-21-327353 Act: 34 Size: 4 MB 网页链接
$美鼎生物(VIVO)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-21-325406 Act: 34 Size: 177 KB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-21-028577 Size: 7 KB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-21-028580 Size: 6 KB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-21-028572 Size: 7 KB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-21-028575 Size: 6 KB 网页链接
$美鼎生物(VIVO)$ 8-K Current report, items 2.03 and 9.01 Accession Number: 0001193125-21-313313 Act: 34 Size: 1 MB 网页链接
$美鼎生物(VIVO)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-21-263299 Act: 34 Size: 210 KB 网页链接
$美鼎生物(VIVO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-21-238736 Act: 34 Size: 7 MB 网页链接